President & CEO Happel David sold $497,068 worth of Series A Common Stock (64,051 units at $7.76), decreasing direct ownership by 8% to 741,570 units (SEC Form 4) (for tax liability)

ByQuantisnow·Wall Street's wire, on your screen.

SGMT· Sagimet Biosciences Inc.

Health Care

Original source

President & CEO Happel David sold $497,068 worth of Series A Common Stock (64,051 units at $7.76), decreasing direct ownership by 8% to 741,570 units (SEC Form 4) (for tax liability) | Quantisnow